Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on January 25, 2019. The report addresses Item 5.02 regarding the approval of 2018 fiscal year cash bonus payments for named executive officers and the Chief Financial Officer by the Compensation Committee.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to specific executive compensation:
- Dean Irwin (CEO): $175,200
- Jeffrey Kraws (Co-President): $114,000
- Andrew Jackson (CFO): $109,494
- Melissa Burstein (EVP): $77,000
Total disclosed bonuses for these four executives amount to $475,694. Payments are expected to be made in the first half of March 2019, less applicable withholdings.
Material Changes
The filing does not report material changes to financial performance, operations, or capital structure compared to prior periods. The primary event is the administrative approval of performance-based compensation tied to 2018 accomplishments, including the completion of the Company's initial public offering.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, market outlook, or discussion of risks and contingencies. Management commentary is limited to the rationale for the bonuses, which were based on individual performance and Company achievements during 2018.
Investor Verification Checklist
- Verify the registrant name is Ra Medical Systems, Inc., not Catheter Precision, Inc.
- Confirm the timing of bonus disbursement (first half of March 2019) against cash flow projections.
- Review the 2018 employment agreements to validate the bonus targets referenced in the filing.
- Check subsequent filings for the actual payment of these bonuses and any associated tax withholdings.